Share thisOn 24 February 2010, NIH and FDA announced a new joint initiative to accelerate conversion of scientific discoveries to medical therapies for human patients.1
Under this initiative, which will combine adapting scientific discoveries to treatments and the development of efficient, effective, and safe medical products, NIH and FDA will jointly:
- Establish an NIH-FDA Leadership Council to help collaboration on important public health issues, integrate regulatory considerations into research planning, and include the latest science in the regulatory review process.
- Issue Requests for Applications for up to $6.75 M over three years allocated for work in regulatory science.
- Provide new methods, models, and technologies that will inform the scientific and regulatory community about improved methods for evaluating safety and efficacy of medical products.
- Speed the application of new scientific discoveries to treatments for patients.
- Hold a public meeting in the spring 2010 to solicit advice on improving this collaboration between NIH and FDA.
REFERENCE
- NIH and FDA Announce Collaborative Initiative to Fast-track Innovations to the Public. NIH-FDA News Release. February 24, 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm201706.h
Veterinarian Moshe Shalev, MSc (Genetics), VMD, is a Diplomate of the American College of Laboratory Animal Medicine. A recognized expert in medicine, management, and facility designs of small, farm, and exotic laboratory animals, he publishes regularly on animal welfare regulations.